Your browser doesn't support javascript.
loading
Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study.
Kim, Ki Hwan; Kim, Chun Soo; Kim, Hwang Min; Kim, Jong-Duck; Ma, Sang Hyuk; Kim, Dong Ho; Hwang, Pyoung-Han; Han, Ji-Whan; Lee, Taek-Jin; Kim, Joon Hyung; Karkada, Naveen; Mesaros, Narcisa; Sohn, Woo-Yun; Kim, Jong-Hyun.
Affiliation
  • Kim KH; a Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea Incheon, The Republic of Korea.
  • Kim CS; b Keimyung University School of Medicine , Daegu , The Republic of Korea.
  • Kim HM; c Yonsei University Wonju College of Medicine , Wonju , The Republic of Korea.
  • Kim JD; d Wonkwang University Hospital , Iksan , The Republic of Korea.
  • Ma SH; e Changwon Fatima Hospital , Changwon , The Republic of Korea.
  • Kim DH; f Korea Cancer Center Hospital , Seoul , The Republic of Korea.
  • Hwang PH; g Chonbuk National University Hospital, Chonbuk National University Medical School , Jeonju , The Republic of Korea.
  • Han JW; h Uijeongbu St. Mary's Hospital , The Catholic University of Korea , Uijeongbu , The Republic of Korea.
  • Lee TJ; i Bundang CHA Hospital , Seongnam , The Republic of Korea.
  • Kim JH; j GSK , Seoul , The Republic of Korea.
  • Karkada N; k GSK , Wavre , Belgium.
  • Mesaros N; k GSK , Wavre , Belgium.
  • Sohn WY; l GSK , Seoul , The Republic of Korea.
  • Kim JH; m St. Vincent's Hospital, College of Medicine , The Catholic University of Korea , Suwon , The Republic of Korea.
Hum Vaccin Immunother ; 15(2): 317-326, 2019.
Article in En | MEDLINE | ID: mdl-30431387
ABSTRACT
We assessed the immunogenicity and safety of a three-dose primary vaccination schedule with the combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus/Haemophilus influenzae type b vaccine (DTPa-IPV/Hib) in Korean infants. In this phase III open-label, multicenter study (NCT01309646), healthy infants aged 42-69 days (randomized 11) received three doses of either pentavalent DTPa-IPV/Hib (DTPa-IPV/Hib group) or DTPa-IPV and Hib vaccines administered separately (DTPa-IPV+Hib group) at 2, 4, 6 months of age. The primary objective was to demonstrate non-inferiority of DTPa-IPV/Hib compared to DTPa-IPV+Hib vaccines in terms of immune responses to all vaccine antigens, 1 month post-dose 3. Solicited symptoms (local and general) were recorded during 4 days, and unsolicited adverse events (AEs) during 31 days, after each vaccination. Serious AEs (SAEs) were recorded throughout the study duration. The immunogenicity of the pentavalent DTPa-IPV/Hib vaccine was non-inferior compared to concomitant administration of DTPa-IPV+Hib vaccines. One month post-dose 3, nearly all infants had antibody levels above the seroprotective thresholds for anti-diphtheria toxoid, anti-tetanus toxoid, anti-polyribosyl-ribitol phosphate, and anti-poliovirus type 1, 2 and 3, and had antibody levels above the seropositive thresholds for anti-pertussis toxoid (PT), anti-filamentous hemagglutinin (FHA) and anti-pertactin (PRN) antibodies. A vaccine response for PT, FHA and PRN was observed in at least 96.7% of study participants. Anti-PRP geometric mean concentrations appeared lower for the DTPa-IPV/Hib group (8.456 µg/mL) than for the DTPa-IPV+Hib group (18.700 µg/mL). In both groups, the most common solicited symptoms were injection site redness and irritability. Fifty-seven SAEs were reported throughout the study; none were considered to be vaccination related.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Poliovirus Vaccine, Inactivated / Diphtheria-Tetanus-Pertussis Vaccine / Immunization Schedule / Haemophilus Vaccines / Immunogenicity, Vaccine / Antibodies, Bacterial / Antibodies, Viral Type of study: Clinical_trials Limits: Female / Humans / Infant / Male Country/Region as subject: Asia Language: En Journal: Hum Vaccin Immunother Year: 2019 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Poliovirus Vaccine, Inactivated / Diphtheria-Tetanus-Pertussis Vaccine / Immunization Schedule / Haemophilus Vaccines / Immunogenicity, Vaccine / Antibodies, Bacterial / Antibodies, Viral Type of study: Clinical_trials Limits: Female / Humans / Infant / Male Country/Region as subject: Asia Language: En Journal: Hum Vaccin Immunother Year: 2019 Document type: Article